HALO
#797
Halozyme Therapeutics, Inc. - Common Stock
110.7 6 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.00%
Variación mensual
+32.01%
Variación en los últimos 6 meses
+60.24%
Cambio anual
+65.81%
Cierres anteriores
109.6 6
Open
110.7 6
Mínimo
110.7 6
Máximo
110.7 6
Volumen
122
Financials
- Market Capitalization 12.57 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
22.89
Relación precio/flujo de caja
5.77
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 753 |  SMMT Summit Therapeutics Inc. - Common Stock | 17.13 USD | +17.33% | +21.40% | +23.15% | -13.75% | 13.67 B USD | ||
| 782 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.43 USD | -0.81% | +2.22% | +8.09% | +17.28% | 12.86 B USD | ||
| 802 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 542.61 USD | -0.79% | +0.60% | +6.21% | +28.09% | 12.54 B USD | ||
| 813 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 86.49 USD | +1.31% | -1.45% | -1.14% | +121.20% | 12.22 B USD |